FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W326870062> ?p ?o ?g. }

• W326870062 endingPage "1055" @default.
• W326870062 startingPage "1048" @default.
• W326870062 abstract "Mevalonate kinase deficiency is a rare disease whose worst manifestation, characterised by severe neurologic impairment, is called mevalonic aciduria. The progressive neuronal loss associated to cell death can be studied in vitro with a simplified model based on a biochemical block of the mevalonate pathway and a subsequent inflammatory trigger. The aim of this study was to evaluate the effect of the mevalonate blocking on glial cells (BV-2) and the following effects on neuronal cells (SH-SY5Y) when the two populations were cultured together. To better understand the cross-talk between glial and neuronal cells, as it happens in vivo, BV-2 and SH-SY5Y were co-cultured in different experimental settings (alone, transwell, direct contact); the effect of mevalonate pathway biochemical block by Lovastatin, followed by LPS inflammatory trigger, were evaluated by analysing programmed cell death and mitochondrial membrane potential, cytokines' release and cells' morphology modifications. In this experimental condition, glial cells underwent an evident activation, confirmed by elevated pro-inflammatory cytokines release, typical of these disorders, and a modification in morphology. Moreover, the activation induced an increase in apoptosis. When glial cells were co-cultured with neurons, their activation caused an increase of programmed cell death also in neuronal cells, but only if the two populations were cultured in direct contact. Our findings, being aware of the limitations related to the cell models used, represent a preliminary step towards understanding the pathological and neuroinflammatory mechanisms occurring in mevalonate kinase diseases. Contact co-culture between neuronal and microglial cells seems to be a good model to study mevalonic aciduria in vitro, and to contribute to the identification of potential drugs able to block microglial activation for this orphan disease. In fact, in such a pathological condition, we demonstrated that microglial cells are activated and contribute to neuronal cell death. We can thus hypothesise that the use of microglial activation blockers could prevent this additional neuronal death." @default.
• W326870062 created "2016-06-24" @default.
• W326870062 creator A5045833196 @default.
• W326870062 creator A5059344737 @default.
• W326870062 creator A5060953179 @default.
• W326870062 creator A5068688381 @default.
• W326870062 creator A5083955983 @default.
• W326870062 creator A5091902364 @default.
• W326870062 date "2015-05-24" @default.
• W326870062 modified "2023-09-27" @default.
• W326870062 title "Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency" @default.
• W326870062 cites W1551468399 @default.
• W326870062 cites W1604026883 @default.
• W326870062 cites W1950464121 @default.
• W326870062 cites W1965016726 @default.
• W326870062 cites W1965086973 @default.
• W326870062 cites W1966804090 @default.
• W326870062 cites W1972296893 @default.
• W326870062 cites W1978567629 @default.
• W326870062 cites W2006161539 @default.
• W326870062 cites W2016452636 @default.
• W326870062 cites W2023584200 @default.
• W326870062 cites W2025921501 @default.
• W326870062 cites W2044219916 @default.
• W326870062 cites W2059491535 @default.
• W326870062 cites W2059943724 @default.
• W326870062 cites W2060042009 @default.
• W326870062 cites W2063449166 @default.
• W326870062 cites W2067267561 @default.
• W326870062 cites W2069610235 @default.
• W326870062 cites W2092055932 @default.
• W326870062 cites W2092333831 @default.
• W326870062 cites W2096790403 @default.
• W326870062 cites W2099337172 @default.
• W326870062 cites W2102497552 @default.
• W326870062 cites W2109307284 @default.
• W326870062 cites W2117515483 @default.
• W326870062 cites W2123026411 @default.
• W326870062 cites W2128971541 @default.
• W326870062 cites W2130693970 @default.
• W326870062 cites W2131686384 @default.
• W326870062 cites W2151283331 @default.
• W326870062 cites W2171241497 @default.
• W326870062 cites W2326510358 @default.
• W326870062 doi "https://doi.org/10.1007/s10495-015-1139-8" @default.
• W326870062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26003816" @default.
• W326870062 hasPublicationYear "2015" @default.
• W326870062 type Work @default.
• W326870062 sameAs 326870062 @default.
• W326870062 citedByCount "11" @default.
• W326870062 countsByYear W3268700622016 @default.
• W326870062 countsByYear W3268700622017 @default.
• W326870062 countsByYear W3268700622018 @default.
• W326870062 countsByYear W3268700622019 @default.
• W326870062 countsByYear W3268700622020 @default.
• W326870062 countsByYear W3268700622022 @default.
• W326870062 crossrefType "journal-article" @default.
• W326870062 hasAuthorship W326870062A5045833196 @default.
• W326870062 hasAuthorship W326870062A5059344737 @default.
• W326870062 hasAuthorship W326870062A5060953179 @default.
• W326870062 hasAuthorship W326870062A5068688381 @default.
• W326870062 hasAuthorship W326870062A5083955983 @default.
• W326870062 hasAuthorship W326870062A5091902364 @default.
• W326870062 hasBestOaLocation W3268700622 @default.
• W326870062 hasConcept C134651460 @default.
• W326870062 hasConcept C169760540 @default.
• W326870062 hasConcept C181199279 @default.
• W326870062 hasConcept C185592680 @default.
• W326870062 hasConcept C190283241 @default.
• W326870062 hasConcept C203014093 @default.
• W326870062 hasConcept C2776914184 @default.
• W326870062 hasConcept C2779830541 @default.
• W326870062 hasConcept C2779982574 @default.
• W326870062 hasConcept C2780884517 @default.
• W326870062 hasConcept C31573885 @default.
• W326870062 hasConcept C529278444 @default.
• W326870062 hasConcept C54355233 @default.
• W326870062 hasConcept C55493867 @default.
• W326870062 hasConcept C81885089 @default.
• W326870062 hasConcept C86803240 @default.
• W326870062 hasConcept C95444343 @default.
• W326870062 hasConceptScore W326870062C134651460 @default.
• W326870062 hasConceptScore W326870062C169760540 @default.
• W326870062 hasConceptScore W326870062C181199279 @default.
• W326870062 hasConceptScore W326870062C185592680 @default.
• W326870062 hasConceptScore W326870062C190283241 @default.
• W326870062 hasConceptScore W326870062C203014093 @default.
• W326870062 hasConceptScore W326870062C2776914184 @default.
• W326870062 hasConceptScore W326870062C2779830541 @default.
• W326870062 hasConceptScore W326870062C2779982574 @default.
• W326870062 hasConceptScore W326870062C2780884517 @default.
• W326870062 hasConceptScore W326870062C31573885 @default.
• W326870062 hasConceptScore W326870062C529278444 @default.
• W326870062 hasConceptScore W326870062C54355233 @default.
• W326870062 hasConceptScore W326870062C55493867 @default.
• W326870062 hasConceptScore W326870062C81885089 @default.
• W326870062 hasConceptScore W326870062C86803240 @default.
• W326870062 hasConceptScore W326870062C95444343 @default.

• next